## (56) References Cited 

Ebadi et al., "Healing effect of topical nifedipine on skin wounds of diabetic rats," DARU, 2003, 11(1):19-22. 

Effendy and Maibach. "Surfactants and Experimental Irritant Con› tact Dermatitis." Contact Dermatol., 1995, 33:217-225. 

Elias and Ghadially, "The aged epidermal permeability barrier," Clinical Geriatric Medicine, Feb. 2002, pp. 103-120. 

Fantin et al., "Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (Quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus," Antimicrob Agents and Chemothery, 1999, 39:400-405. 

Fluhr et al., "Glycerol accelerates recovery of barrier function in vivo," Acta Derm. Venereal,. 1999, 79:418-21. 

Garti et al. "Sucrose Esters microemulsions," J Malec. Liquids, 1999, 80:253-296. 

Hammer et al. "Anti-Microbial Activity of Essential Oils and other Plant extracts," J Applied Microbiology, 1999, 86:985-990. 

Hwang et al. "Isolation and identification of mosquito repellents in Artemisia vulgaris," J Chem. Ecol., 11: 1297-1306, 1985. 

Knight et al., "Topical diltiazem ointment in the treatment of chronic anal fissure," Br. J Surg., 2001, 88(4):553-6. 

Kucharekova et al., "Effect of a lipid-rich emollient containing ceramide 3 in experimentally induced skin barrier dysfunction," Con› tact Dermatitis, Jun. 2002, pp. 331-338. 

Leive et al, "Tetracyclines of various hydrophobicities as a probe for permeability of Escherichia coli outer membrane," Antimicrobial Agents and Chemotherapy, 1984, 25:539-544. 

Luepke and Kemper, "The HET-CAM Test: An Alternative to the Draize Eye Test," FD Chem,. Toxic., 1986, 24:495-196. 

Osborne and Henke, "Skin Penetration Enhancers Cited in the Tech› nical Literature," Pharm. Technology, Nov. 1997, pp. 58-86. 

Padi. "Minocycline prevents the development of neuropathic pain, but not acute pain: possible anti-inflammatory and antioxidant mechanisms," Eur J Pharmacol, 2008, 601 :79-87. 

Palamaras and Kyriakis, "Calcium antagonists in dermatology: a review of the evidence and research-based studies," Derm. Online Journal, 2005, 11(2):8. 

Passi et al., Lipophilic antioxidants in human sebum and aging, Free Radical Research, 2002, pp. 471-477. 

Perrotti et al., "Topical Nifedipine With Lidocaine Ointment vs. Active Control for Treatment of Chronic Anal Fissure," Dis Colon Rectum, 2002, 45(11): 1468-1475. 

Repa et al. "All-trans-retinol is a ligand for the retinoic acid recep› tors," Proc. Natl. Acad Sci, USA, 90: 7293-7297, 1993. 

Ruledge, "Some corrections to the record on insect repellents and attractants," J Am. Mosquito Control Assoc, 1988, 4(4): 414-425. 

Sakai et al., "Characterization of the physical properties of the stra› tum corneum by a new tactile sensor," Skin Research and Technology, Aug. 2000, pp. 128-134. 

Schaefer, "Silicone Surfactants," Tenside, Surfactants, Deterg., 1990, 27(3): 154-158. 

Simoni et al., "Retinoic acid and analogs as potent inducers of dif› ferentiation and apoptosis. New promising chemopreventive and chemotherapeutic agents in oncology," Pure Appl Chem., 2001, 73(9): 1437-1444. 

Smith, "Hydroxy acids and skin again," Soap Cosmetics Chemical Specialties, 1993, pp. 54-59. 

Solans et al. "Overview of basic aspects ofmicroemulsions," Indus› trial Applications of Microemulsions, Solans et al Eds, New York, 1997, 66:1-17. 

Squillante et al., "Codiffusion of propylene glycol and dimethyl isosorbide in hairless mouse skin," European J Pharm. Biopharm., 1998, 46(3):265-71. 

Todd et al. "Volatile Silicone Fluids for Cosmetics," 91 Cosmetics and Toiletries, 1976, 27-32. 

Torma et al., "Biologic activities of retinoic acid and 3, 4-dehydroretinoic acid in human keratinoacytes are similar and cor› relate with receptor affinities and transactivation properties," J invest. Dermatology, 1994, 102: 49-54. 

## OTHER PUBLICATIONS 

USP23/NF 18 The United States Pharmacopeia: The National For› mulary, US Pharmacopoeia, 1995, p. 10-14. 

Van Slyke, "On the measurement of buffer values and on the rela› tionship of buffer value to the dissociation constant of the buffer and the concentration and reaction of the buffer solution," J Biol. Chem., 1922, 52:525-570. 

Van Cutsem et al., "The antiinflammatory efects ofketoconazole," J Am. Acad. Dermatol.,1991, 25(2 pt 1):257-261. 

Wang and Chen, "Preparation and surface active properties of bio› degradable dextrin derivative surfactants," Colloids and Surfaces A: Physicochemical and Engineering Aspects, 2006, 281( 1-3): 190-193. Weindl et al., "Hyaluronic acid in the treatment and prevention of skin diseases: molecular biological, pharmaceutical and clinical aspects," Skin Pharmacology and Physiology, 2004, 17: 207-213. 

Xynos et al., "Effect ofnifedipine on rectoanal motility," Dis Colon Rectum, 1996, 39(2):212-216. 

Yamada et al., "Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats," J Pharmacol. Exp. Ther., 2003, 307(1)17-23. 

Paragraph E.3.1 of regulation (EC) No. 2003 (See Directive 67/548/ EEC OJ 196, 16.8, 1967, p. 1. 

Tzen et al., Lipids, proteins and structure of seed oil bodies from diverse species; Plant Physiol., 1993, 101:267-276. 

Brown et al. "Structural dependence of flavonoid interactions with Cu2+ inos: implications for their antioxidant properties," Biochem. J, 1998, 330:1173-1178. 

Cloez-Tayarani. et al., "Differential effect of serotonin on cytokine production in lipopolysaccharide-stimulatedhuman peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A recep› tors," lnt. lmmunol., 2003, 15:233-40. 

"Mineral oil USP," Chemical Abstracts Service Registry No. 8012- 95-1, 2011, 7 pages. 

"Tea tree oil," Chemical Abstract No. 68647-73-4, 2012, 2 pages. Lin et al., "Ferulic acid stabilizes a solution of vitamins c and e and doubles its protoprotection of skin," J invest Dermatol, 2005, 125:826-32. 

International Preliminary Report on Patentability from PCT /IB2007 / 004628, dated Jun. 3, 2009, 6 pages; International Search Report, dated May 6, 2009, 4 pages. 

"Arquad HTL8-MS," AkzoNobel Functional Applications, retrieved on Mar. 18, 2013, Retrieved from the Internet: <URL: http://sc. akzono be! .corn/ en/fa/Pages/product -detail .aspx?prodID~87 64>, 1 page. 

"Burn patients need vitamin D supplements." Decision News Media, Jan. 23, 2004, http://www.nutraingredients.com/Research/Burn-pa› tients-need-vitamin-D-supplements, Accessed: May 5, 2010. 

"Can tuberous sclerosis be prevented?," Sharecare, 2002, retrieved on Aug. 29, 2013, <URL: http://www.sharecare.com/health/ autosomal-dominant-genetic-disorders/can-tuberous-sclerosis-be› prevented;j sessionid~850 579B605 20A907DE7 5930E06 l E60E6>, 2 pages. 

"Crohn’s Disease," Merch Manual Home Edition, retrieved on Jan. 16, 2013, <http://www.merckmanuals.com/home/digestive_disor› ders/inflammatory _bowel_diseases_ibd/crohn_disease. html?qt~crohn’s disease&alt~sh>, 3 pages. 

"Dacarbazine," Chemical Book, 2010, retrieved on Oct. 18, 2013, <URL: http://www.chemicalbook.com/ChemicalProductProperty_ EN_CB7710656.htm>, 2 pages. 

"Drug Index (Professional)-Dacarbazine," BC Cancer Agency, Jun. 2004, retrieved on Oct. 18, 2013, <URL:http://www.bccancer.bc.ca/ HPI/DrugDatabase/DrugindexPro/Dacarbazine.htm>, 6 pages. 

"Fully refined paraffin waxes (FRP Wax)," Industrial Raw Materials LLC, Feb. 21, 2008, retrieved on Aug. 22, 2013, <http:/ /irmwax.corn/ Wax/Paraffin/fully _refined.asp> 1 page. 

"Gas Gangrene," Merch Manual Home Edition, 2008, retrieved on Jan. 16, 2013, <http://www.merckmanuals.com/home/infections/ bacterial_infections/gas_gangrene.html?qt~gasgangrene &alt~sh> 1 page. 

"HLB Systems", http:/ /pharmcal.tripod.corn/chl 7.htm, Accessed Sep.17, 2010, pp.1-3. 

"Human Immunodeficiency Virus Infection," Merch Manual Home Edition, 2008, retrieved on Jan. 16, 2013, <http://www.merckmanu› als.com/home/infections/human_immunodeficiency _ virus_hiv _ 

